New MSF report reveals countries struggle with skyrocketing vaccine prices amidst market shrouded in secrecy Médecins Sans Frontières (MSF) today called on pharmaceutical companies GlaxoSmithKline (GSK) and Pfizer to slash the price of the pneumococcal vaccine to US$5 per child in developing...
Phumeza TISILE, co-author of the DR-TB Manifesto* and XDR-TB survivor, delivers urgent plea to World Health Assembly delegates on behalf of 50,000 supporters worldwide On the eve of the World Health Assembly adopting an ambitious 20-year global plan to address tuberculosis (TB) and drug-resistant...
24th March is the World Tuberculosis (TB) Day. A new briefing paper by Médecins Sans Frontières (MSF) outlines why the alarming spread of deadly strains of drug-resistant tuberculosis (DR-TB) is one of the biggest global health threats we face today. It calls on governments, pharmaceutical...
‘Patent opposition’ seeks to ensure production of affordable generics Médecins Sans Frontières (MSF) supports the ‘patent opposition’ just filed at India’s Patent Office by the Initiative for Medicines, Access & Knowledge (I-MAK), which aims to prevent US pharmaceutical company Gilead/...
Access Campaign The Union World Conference on Lung Health was held in Paris. MSF urged for a new approach to developing and pricing new tuberculosis (TB) medicines, so that the global TB response can deliver the new treatment combinations needed to close the deadly treatment gap for drug-resistant...
Several key policy changes are urgently needed at the GAVI Alliance to help reduce the number of children not benefitting from vaccination globally (22.6 million in 2012), Medecins Sans Frontieres (MSF) said ahead of GAVI’s progress review meeting in Stockholm. “We fully support GAVI’s mission of...
Access Campaign As Asia-Pacific leaders prepare to meet in Bali for the APEC Summit, where the 12-country Trans-Pacific Partnership Agreement trade deal will be high on the agenda, MSF urged governments not to make political trade-offs during trade negotiations that will harm access to affordable...
Access Campaign With the start of the Trans-Pacific Partnership Agreement (TPP) negotiations taking place in Brunei in August, MSF warned that the negotiators were moving towards finalizing a deal that in fact would restrict access to affordable medicines and constrain governments’ ability to...
The far-reaching Trans-Pacific Partnership Agreement (TPP) should be a force for improving health outcomes for the more than half a billion people in twelve countries affected by the pact, but instead negotiators are moving towards finalizing a deal that in fact would restrict access to affordable...
Country’s first international symposium to tackle DR-TB crisis begins 22 August An urgent health threat in Myanmar is drawing together leading experts to explore new ways to tackle the drug-resistant TB (DR-TB) crisis. Forms of TB that cannot be treated with standard drugs are presenting at an...
